ＪＣＲファーマ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4552/E00973 | JCR Pharmaceuticals Co., Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2011/08/26 | 日証協 | 179,400株 | 0% | 0株 | 0.00% | 182,736株 | +0.05% | 0株 | 0.00% |
| 2011/08/19 | 日証協 | 179,400株 | -0.33% | 0株 | -100% | 182,636株 | -0.6% | 100株 | -99.62% |
| 2011/08/12 | 日証協 | 180,000株 | -3.33% | 15,100株 | -59.26% | 183,736株 | +20.45% | 26,600株 | -23.12% |
| 2011/08/05 | 日証協 | 186,200株 | -8.81% | 37,063株 | +4018.11% | 152,536株 | -18.79% | 34,600株 | +24.91% |
| 2011/07/29 | 日証協 | 204,200株 | -9.08% | 900株 | -91% | 187,836株 | -3.49% | 27,700株 | +237.6% |
| 2011/07/22 | 日証協 | 224,600株 | -1.62% | 10,000株 | 0% | 194,636株 | -0.71% | 8,205株 | 0% |
| 2011/07/15 | 日証協 | 228,300株 | -2.73% | 0株 | 0.00% | 196,031株 | +16.66% | 0株 | 0.00% |
| 2011/07/08 | 日証協 | 234,700株 | -3.02% | 0株 | 0% | 168,031株 | +2.69% | 38,500株 | +9999.99% |
| 2011/07/01 | 日証協 | 242,000株 | -7.07% | 0株 | -100% | 163,631株 | -4.38% | 101株 | -98.91% |
| 2011/06/24 | 日証協 | 260,400株 | -5.41% | 500株 | -80% | 171,131株 | -16.41% | 9,300株 | +447.06% |
| 2011/06/17 | 日証協 | 275,300株 | -9.35% | 2,500株 | 0% | 204,731株 | -10.57% | 1,700株 | +183.33% |
| 2011/06/10 | 日証協 | 303,700株 | -1.84% | 0株 | 0% | 228,931株 | -0.78% | 600株 | +50% |
| 2011/06/03 | 日証協 | 309,400株 | -1.31% | 0株 | -100% | 230,731株 | -0.04% | 400株 | -20% |
| 2011/05/27 | 日証協 | 313,500株 | -7.6% | 40,100株 | -29.77% | 230,831株 | -8.48% | 500株 | -97.04% |
| 2011/05/20 | 日証協 | 339,300株 | +1.37% | 57,100株 | +32.79% | 252,231株 | +7.18% | 16,900株 | -46.86% |
| 2011/05/13 | 日証協 | 334,700株 | +2.39% | 43,000株 | +91.96% | 235,331株 | +4.95% | 31,800株 | +150.39% |
| 2011/05/06 | 日証協 | 326,900株 | -0.06% | 22,400株 | +45.45% | 224,231株 | +0.22% | 12,700株 | +353.57% |
| 2011/04/28 | 日証協 | 327,100株 | -0.43% | 15,400株 | -30.63% | 223,731株 | -5.69% | 2,800株 | -73.08% |
| 2011/04/22 | 日証協 | 328,500株 | -2.06% | 22,200株 | +76.19% | 237,231株 | +0.72% | 10,400株 | +50.72% |
※株式分割は考慮していませんのでご注意ください。